Advisory Committee

  • Dato’ Eisah Abdul Rahman - Senior Director, Pharmaceutical Services, Ministry of Health, Malaysia
  • John Lim - Deputy Director of Medical Services, Ministry of Health and Executive Director, Centre of Regulatory Excellence, Duke-NUS Graduate Medical School, Singapore
  • Michelle Limoli, Pharm.D., Associate Director for International Programs, CDER, US FDA
  • Lembit Rago, Head, Regulation of Medicines & other Health Technologies,  WHO, Switzerland
  • Sun-Hee Lee, Director General, Drug Evaluation Department, MFDS, South Korea
  • Li Lin Liu, Director, Division of Medicinal Products, TFDA, Chinese Taipei
  • Mike Ward, Chair, Regulatory Harmonization Steering Committee - APEC ; Manager, International Programs Division, Health Canada, Canada
  • Nobumasa Nakashima, International Planning Director, Pharmaceutical Affairs, MHLW, Japan
  • Tomas Salmonson, Chair, Committee for Medicinal Products for Human Use, EMA; Senior Scientific Advisor, Läkemedelsverket, Sweden
  • Kenneth Hartigan-Go, Director-General, Food and Drugs Administration, Department of Health, Republic of the Philippines
  • Yuppadee Javroongrit, Senior Expert on Pharmaceuticals Standard, Bureau of Drug Control, Thai FDA, Ministry of Public Health, Thailand
  • Petra Dorr, Head of Communication and Networking; Deputy Director, Swissmedic, Switzerland
  • Jytte Lyngvig, Senior Vice-President; Managing Director, DIA Europe, Middle East & Africa, DIA, Switzerland
  • Romi Singh, Ph.D. Executive Director, Global Regulatory Affairs & Safety, Amgen, United States
  • Estelle Michael, Senior Director, Regulatory Policy - Emerging Markets, AstraZeneca
  • Toshihiko Tsunenari, Director, Global Regulatory Affairs, JPMA
  • Sharon Olmstead, Chair, Regulatory Policy and Technical Standards Committee – IFPMA, Global Head, Development & Regulatory Policy, Drug Regulatory Affairs, Novartis)
  • David Jefferys, Senior Vice President, Global Regulatory, Healthcare Policy and Government Relations, Eisai
  • Chih-Ping Yang, President – IRPMA; General Manager, Chugai Pharma
  • Heather Lin, Director General, IRPMA
  • Caroline Mendy, Manager Regulatory Policy, IFPMA
  • Nobuki Sato, Japan Liaison Executive, IFPMA
  • Cristina Arnés, Research Associate, IFPMA
  • Sadia Kaenzig, Manager Communications, IFPMA